Cas No.86520-63-0 2,3,4,6-Tetra-O-acetyl-α-glucopyranosyl 2,2,2-Trichloroacetimidate

Glycoside drugs are an important component of many antiviral, antibacterial, anticancer, and immunomodulatory drugs. By using this compound, glycosylation drugs can be effectively synthesized, which often bind to targeted proteins or receptors through glycosidic bonds, thereby regulating their biological activity. Glycosylation modification can improve the solubility, metabolic stability, and biological targeting of drugs. Glycosylation modification has important applications in cancer and viral therapy. Carbohydrates can affect cellular signaling pathways by binding to sugar receptors or proteins on the cell surface. This allows the compound to be used in the development of anticancer and antiviral glycoside drugs.